RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PAVONI C
Collezione AO Cuneo

Items : 6

Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial. in Blood cancer journal / Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5.

2024
AO Cuneo
AOU Città della Salute di Torino

Iori AP; Bernasconi P; Corradini P; Russo D; Nagler A; Carella AM; Marotta G; Cerretti R; Rivela P; Terruzzi E; Saporiti G; Pane F; Patriarca F; Saccardi R; Musto P; Chiusolo P; Olivieri A; Milone G; Santarone S; Borghero C; Cavattoni IM; Busca A; Micò MC; Pavoni C; Grassi A; Cavallaro G; Castagna L; Mordini N; Oldani E; et alii...

Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):415-423. doi: 10.1002/hon.3117. Epub 2023 Jan 4.

2023
AO Cuneo

Biggi A; Chauvie S; Fallanca F; Guerra L; Bergesio F; Menga M; Bianchi A; Gregianin M; Chiaravalloti A; Schillaci O; Pavoni C; Patti C; Picardi M; Romano A; Schiavotto C; Sorasio R; Viviani S; La Nasa G; Trentin L; Rambaldi A; Gallamini A;

Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.

2020
AO Cuneo
AO Ordine Mauriziano

Gianni AM; Gallamini A; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Trentin L; Sorasio R; Romano A; Patti C; Rossi A; Taverna F; Rambaldi A; Pavoni C; Mazzocchi A; Viviani S;

Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Nov 20;38(33):3905-3913. doi: 10.1200/JCO.20.00935. Epub 2020 Sep 18.

2020
AO Cuneo

Mulé A; Viero P; Schiavotto C; Cimminiello M; Zanotti R; Pavoni C; Sorasio R; Chauvie S; Battistini R; Gini G; Trentin L; Bolis S; Viviani S; Oppi S; Cantonetti M; Romano A; Picardi M; Patti C; Rossi A; Gallamini A; Fallanca F; Ficola U; Tarella C; Guerra L; Rambaldi A;

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial. in Cancer medicine / Cancer Med. 2020 Dec;9(23):8735-8746. doi: 10.1002/cam4.3396. Epub 2020 Nov 6.

2020
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gallamini A; Massimo Gianni A; Biggi A; Chauvie S; Viero P; Ferreri AJM; Gini G; Schiavotto C; Zanotti R; Parvis G; Corradini P; Cimminiello M; Gavarotti P; Bolis S; Zoli V; Trentin L; La Nasa G; Cantonetti M; Picardi M; Rossi A; Patti C; Viviani S; Di Raimondo F; Tarella C; Pavoni C; Romano A;

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Battistini R; Gottardi D; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...